Literature DB >> 17003929

Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix.

Eli I Lev1, Zeev Estrov, Khatira Aboulfatova, David Harris, Juan F Granada, Carlos Alviar, Neal S Kleiman, Jing-fei Dong.   

Abstract

Endothelial progenitor cells (EPCs) mobilize from the bone marrow in response to tissue injury and participate in vascular repair. However, there is limited data about the homing mechanisms of EPCs to vascular injury sites. Recently animal experiments indicated that platelets play a role in recruitment of EPCs to injury sites. However, data on the possible interaction between platelets and EPCs within the human system are limited. We, therefore, examined in-vitro human platelet-EPC interaction under static and flow conditions. Human EPCs were isolated from donated buffy coats by magnetic microbeads and flow cytometry cell sorting using CD133 and VEGFR-2, respectively, as markers. Platelets were tested in the form of washed platelets, platelet rich plasma or whole blood. EPCs formed heterotypic aggregates with resting platelets under static conditions, an interaction that was greatly enhanced when platelets were activated by collagen, ADP or thrombin-activation peptide. The platelet-EPC interaction was inhibited by antibodies to P-selectin or P-selectin glycoprotein ligand-1 (PSGL-1), but not by antibodies to glycoproteins Ib-IX-V or IIb/IIIa. When perfused over activated platelets under shear stress of 2.5 dyn/cm(2), EPCs tethered to platelayers and either adhered immediately or rolled a short distance before adhering. In addition, platelets promoted the colonization of adherent EPCs in culture conditions. Consistent with recent animal studies, these findings demonstrate that human EPCs interact in vitro with activated platelets under static and flow conditions, mediated through P-selectin-PSGL-1 interaction. This interaction may be a central mechanism for homing of EPCs to vascular injury sites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003929

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  20 in total

1.  Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo.

Authors:  Carlos L Alviar; Armando Tellez; Michael Wang; Pamela Potts; Doug Smith; Manus Tsui; Wladyslaw Budzynski; Albert E Raizner; Neal S Kleiman; Eli I Lev; Juan F Granada; Greg L Kaluza
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

2.  Exposure to platelets promotes functional properties of endothelial progenitor cells.

Authors:  Dorit Leshem-Lev; Alexander Omelchenko; Leor Perl; Ran Kornowski; Alexander Battler; Eli I Lev
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

3.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

Authors:  Andrew A Francis; Grant N Pierce
Journal:  Exp Clin Cardiol       Date:  2011

Review 4.  Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review.

Authors:  Sandip Sarkar; Thomas Schmitz-Rixen; George Hamilton; Alexander M Seifalian
Journal:  Med Biol Eng Comput       Date:  2007-03-06       Impact factor: 2.602

Review 5.  Vascular precursor cells in tissue injury repair.

Authors:  Xin Shi; Weihong Zhang; Liya Yin; William M Chilian; Jessica Krieger; Ping Zhang
Journal:  Transl Res       Date:  2017-02-21       Impact factor: 7.012

6.  Endothelial progenitor cells contribute to the vascularization of endometriotic lesions.

Authors:  Matthias W Laschke; Christian Giebels; Ruth M Nickels; Claudia Scheuer; Michael D Menger
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 7.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

8.  Endothelial progenitor cells correlate with clinical outcome of traumatic brain injury.

Authors:  Li Liu; Huijie Wei; Fanglian Chen; Jinghua Wang; Jing-fei Dong; Jianning Zhang
Journal:  Crit Care Med       Date:  2011-07       Impact factor: 7.598

9.  Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34+ Cells From Atherosclerotic Patients With Type 2 Diabetes.

Authors:  Sylvie Cointe; Éric Rhéaume; Catherine Martel; Olivier Blanc-Brude; Evemie Dubé; Florence Sabatier; Françoise Dignat-George; Jean-Claude Tardif; Arnaud Bonnefoy
Journal:  Cell Transplant       Date:  2016-10-06       Impact factor: 4.064

10.  Endothelial progenitor cells bind and inhibit platelet function and thrombus formation.

Authors:  Haissam Abou-Saleh; Daniel Yacoub; Jean-François Théorêt; Marc-Antoine Gillis; Paul-Eduard Neagoe; Benoit Labarthe; Pierre Théroux; Martin G Sirois; Maryam Tabrizian; Eric Thorin; Yahye Merhi
Journal:  Circulation       Date:  2009-11-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.